ENTITY

Argenx SE (ARGX US)

27
Analysis
Health CareNetherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
Company Presentation30 Oct 2025 20:30
Company Presentation17 Sep 2025 02:00
Company Presentation31 Jul 2025 20:30
Company Presentation08 May 2025 20:30
Company Presentation14 May 2021 20:30
x